The heparin-binding domain confers diverse functions of VEGF-A in development and disease: A structure-function study

Biochemical Society Transactions

Volumn 37, Issue 6, 2009, Pages 1201-1206

  Krilleke, Dominik ^a   Ng, Yin Shan Eric ^a   Shima, David T ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cancer; Heparan sulfate proteoglycan; Heparin binding domain; Leukostasis; Retinal disorder; Vascular endothelial growth factor receptor (VEGFR); Vascular endothelial growth factor A (VEGF A)

Indexed keywords

HEPARIN BINDING PROTEIN; NEUROPILIN 1; PROTEOHEPARAN SULFATE; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; BINDING AFFINITY; DIABETIC RETINOPATHY; EMBRYO DEVELOPMENT; EXTRACELLULAR MATRIX; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; RETINA MACULA AGE RELATED DEGENERATION; RETROLENTAL FIBROPLASIA; STRUCTURE ANALYSIS;

ALTERNATIVE SPLICING; ANIMALS; EYE DISEASES; HEPARAN SULFATE PROTEOGLYCANS; HEPARIN; HUMANS; MICE; MODELS, MOLECULAR; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS;

EID: 70450208952     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0371201     Document Type: Article

References (50)

1. Li, X. and Eriksson, U. (2001) Novel VEGF family members: VEGF-B, VEGF-C and VEGF-D. Int. J. Biochem. Cell Biol. 33, 421-426
2. Lyttle, D.J., Fraser, K.M., Fleming, S.B., Mercer, A.A. and Robinson, A.J. (1994) Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus. J. Virol. 68, 84-92
3. Ferrara, N. (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr. Rev. 25, 581-611
4. Clauss, M., Gerlach, M., Gerlach, H., Brett, J., Wang, F., Familletti, P.C., Pan, Y.C., Olander, J.V., Connolly, D.T. and Stern, D. (1990) Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J. Exp. Med. 172, 1535-1545
5. Olsson, A.K., Dimberg, A., Kreuger, J. and Claesson-Welsh, L. (2006) VEGF receptor signalling: in control of vascular function. Nat. Rev. Mol. Cell Biol. 7, 359-371
6. de Vries, C., Escobedo, J.A., Ueno, H., Houck, K., Ferrara, N. and Williams, L.T. (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255, 989-991
7. Terman, B.I., Dougher-Vermazen, M., Carrion, M.E., Dimitrov, D., Armellino, D.C., Gospodarowicz, D. and Bohlen, P. (1992) Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 187, 1579-1586
8. Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J.C. and Abraham, J.A. (1991) The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266, 11947-11954
9. Houck, K.A., Leung, D.W., Rowland, A.M., Winer, J. and Ferrara, N. (1992) Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem. 267, 26031-26037
10. Keyt, B.A., Berleau, L.T., Nguyen, H.V., Chen, H., Heinsohn, H., Vandlen, R. and Ferrara, N. (1996) The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J. Biol. Chem. 271, 7788-7795
11. Park, J.E., Keller, G.A. and Ferrara, N. (1993) The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Cell 4, 1317-1326
12. Soker, S., Takashima, S., Miao, H.Q., Neufeld, G. and Klagsbrun, M. (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92, 735-745
13. Whitaker, G.B., Limberg, B.J. and Rosenbaum, J.S. (2001) Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF165 and VEGF121. J. Biol. Chem. 276, 25520-25531
14. Murga, M., Fernandez-Capetillo, O. and Tosato, G. (2005) Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2. Blood 105, 1992-1999
15. Wang, L., Zeng, H., Wang, P., Soker, S. and Mukhopadhyay, D. (2003) Neuropilin-1-mediated vascular permeability factor/vascular endothelial growth factor-dependent endothelial cell migration. J. Biol. Chem. 278, 48848-48860
16. Dougher, A.M., Wasserstrom, H., Torley, L., Shridaran, L., Westdock, P., Hileman, R.E., Fromm, J.R., Anderberg, R., Lyman, S., Linhardt, R.J. et al. (1997) Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor. Growth Factors 14, 257-268
17. Ashikari-Hada, S., Habuchi, H., Kariya, Y. and Kimata, K. (2005) Heparin regulates vascular endothelial growth factor 165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells: comparison of the effects of heparin and modified heparins. J. Biol. Chem. 280, 31508-31515
18. Gitay-Goren, H., Soker, S., Vlodavsky, I. and Neufeld, G. (1992) The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J. Biol. Chem. 267, 6093-6098
19. 165 with soluble and cell associated flk-1 receptors. J. Biol. Chem. 269, 12456-12461
20. Terman, B., Khandke, L., Dougher-Vermazan, M., Maglione, D., Lassam, N.J., Gospodarowicz, D., Persico, M.G., Bohlen, P. and Eisinger, M. (1994) VEGF receptor subtypes KDR and FLT1 show different sensitivities to heparin and placenta growth factor. Growth Factors 11, 187-195
21. 121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. J. Biol. Chem. 270, 11322-11326
22. Ito, N. and Claesson-Welsh, L. (1999) Dual effects of heparin on VEGF binding to VEGF receptor-1 and transduction of biological responses. Angiogenesis 3, 159-166
23. 165. J. Biol. Chem. 274, 10816-10822
24. Ruhrberg, C., Gerhardt, H., Golding, M., Watson, R., Ioannidou, S., Fujisawa, H., Betsholtz, C. and Shima, D.T. (2002) Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev. 16, 2684-2698
25. 188. Nat. Med. 5, 495-502
26. 164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. J. Exp. Med. 198, 483-489
27. Stalmans, I., Ng, Y.S., Rohan, R., Fruttiger, M., Bouche, A., Yuce, A., Fujisawa, H., Hermans, B., Shani, M., Jansen, S. et al. (2002) Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J. Clin. Invest. 109, 327-336
28. 120 mice reveal multiple roles for VEGF in skeletogenesis. Development 129, 1893-1904
29. 188 isoforms impairs postnatal glomerular angiogenesis and renal arteriogenesis in mice. J. Am. Soc. Nephrol. 13, 1548-1560
30. Schwarz, Q., Gu, C., Fujisawa, H., Sabelko, K., Gertsenstein, M., Nagy, A., Taniguchi, M., Kolodkin, A.L., Ginty, D.D., Shima, D.T. and Ruhrberg, C. (2004) Vascular endothelial growth factor controls neuronal migration and cooperates with Sema3A to pattern distinct compartments of the facial nerve. Genes Dev. 18, 2822-2834
31. Kim, K.J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H.S. and Ferrara, N. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362, 841-844
32. Guo, P., Xu, L., Pan, S., Brekken, R.A., Yang, S.T., Whitaker, G.B., Nagane, M., Thorpe, P.E., Rosenbaum, J.S., Su Huang, H.J. et al. (2001) Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites. Cancer Res. 61, 8569-8577
33. Grunstein, J., Masbad, J.J., Hickey, R., Giordano, F. and Johnson, R.S. (2000) Isoforms of vascular endothelial growth factor act in a coordinate fashion to recruit and expand tumor vasculature. Mol. Cell. Biol. 20, 7282-7291
34. Cressey, R., Wattananupong, O., Lertprasertsuke, N. and Vinitketkumnuen, U. (2005) Alteration of protein expression pattern of vascular endothelial growth factor (VEGF) from soluble to cell-associated isoform during tumorigenesis. BMC Cancer 5, 128
35. Tokunaga, T., Oshika, Y., Abe, Y., Ozeki, Y., Sadahiro, S., Kijima, H., Tsuchida, T., Yamazaki, H., Ueyama, Y., Tamaoki, N. and Nakamura, M. (1998) Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. Br. J. Cancer 77, 998-1002
36. Lee, S., Jilani, S.M., Nikolova, G.V., Carpizo, D. and Iruela-Arispe, M.L. (2005) Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J. Cell Biol. 169, 681-691
37. Adamis, A.P., Aiello, L.P. and D'Amato, R.A. (1999) Angiogenesis and ophthalmic disease. Angiogenesis 3, 9-14
38. McColm, J.R., Geisen, P. and Hartnett, M.E. (2004) VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP. Mol. Vision 10, 512-520
39. Nishijima, K., Ng, Y.S., Zhong, L., Bradley, J., Schubert, W., Jo, N., Akita, J., Samuelsson, S.J., Robinson, G.S., Adamis, A.P. and Shima, D.T. (2007) Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am. J. Pathol. 171, 53-67
40. 164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2. Invest. Ophthalmol. Visual Sci. 45, 368-374
41. 164 is proinflammatory in the diabetic retina. Invest. Ophthalmol. Visual Sci. 44, 2155-2162
42. Miyamoto, K., Khosrof, S., Bursell, S.E., Rohan, R., Murata, T., Clermont, A.C., Aiello, L.P., Ogura, Y. and Adamis, A.P. (1999) Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc. Natl. Acad. Sci. U.S.A. 96, 10836-10841
43. Qaum, T., Xu, Q., Joussen, A.M., Clemens, M.W., Qin, W., Miyamoto, K., Hassessian, H., Wiegand, S.J., Rudge, J., Yancopoulos, G.D. and Adamis, A.P. (2001) VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest. Ophthalmol. Visual Sci. 42, 2408-2413
44. Barleon, B., Sozzani, S., Zhou, D., Weich, H.A., Mantovani, A. and Marme, D. (1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87, 3336-3343
45. Tordjman, R., Lepelletier, Y., Lemarchandel, V., Cambot, M., Gaulard, P., Hermine, O. and Romeo, P.H. (2002) A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response. Nat. Immunol. 3, 477-482
46. Ishida, S., Shinoda, K., Kawashima, S., Oguchi, Y., Okada, Y. and Ikeda, E. (2000) Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy. Invest. Ophthalmol. Visual Sci. 41, 1649-1656
47. Keck, R.G., Berleau, L., Harris, R. and Keyt, B.A. (1997) Disulfide structure of the heparin binding domain in vascular endothelial growth factor: characterization of posttranslational modifications in VEGF. Arch. Biochem. Biophys. 344, 103-113
48. 164 heparin-binding domain. J. Biol. Chem. 282, 28045-28056
49. Stauffer, M.E., Skelton, N.J. and Fairbrother, W.J. (2002) Refinement of the solution structure of the heparin-binding domain of vascular endothelial growth factor using residual dipolar couplings. J. Biomol. NMR 23, 57-61
50. Lander, A.D. (1994) Targeting the glycosaminoglycan-binding sites on proteins. Chem. Biol. 1, 73-78